跳至主要内容
临床试验/NCT01880554
NCT01880554已完成不适用

Clinical Utility of Contrast-enhanced Intraoperative Ultrasound in Surgery of Colorectal Liver Metastases. Phase II Clinical Trial.

Institut Bergonié1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2011年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
68
试验地点
1
主要终点
Clinical Utility of Intraoperative Contrast Ultrasound in the Surgery of Colorectal Cancer Liver Metastases.

研究概览

简要总结

Hypothesis: Use of contrast ultrasound showed interesting results, which can increase ultrasonography sensitivity performed during surgery in the evaluation of operable liver metastases.

This study is a two-stage phase II multicenter study (Simon's two-stage).

详细描述

Hypothesis

Use of contrast ultrasound showed interesting results, which can increase ultrasonography sensitivity performed during surgery in the evaluation of operable liver metastases.

This study is a two-stage phase II multicenter study (Simon's two-stage).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patient with histological proven colorectal cancer.
  • •Operable liver metastases according to preoperative imagery. Operability is the possibility of treatment by resection and/or local destruction (radiofrequency, cryotherapy…).
  • •Patient treated or not with preoperative chemotherapy.
  • •With or without extra-hepatic metastases
  • •Age ≥ 18 years.
  • •Radiological assessment by CT and MRI liver and positron emission tomography scan (PETscan) within six weeks before surgery.
  • •Patient affiliated to the Social Security system.
  • •Signed informed consent.

排除标准

  • •Known hypersensitivity to sulfur hexafluoride or another component of SonoVue®.
  • •Patients with recent acute coronary syndrome or suffering from unstable ischemic heart disease, especially: evolving myocardial infarction, unstable angina during the last 7 days, recent coronary intervention or another factor suggesting clinical instability, acute heart failure, class III or IV heart failure, severe arrhythmias.
  • •Patients with right-to-left shunt, severe pulmonary arterial hypertension, uncontrolled systemic hypertension, as patients suffering from respiratory distress syndrome.
  • •Pregnant and lactating women.
  • •Patients with contraindication for a CT scan, a MRI or a positron emission tomography (PET) with contrast.
  • •Patients with indication of two step liver surgery.
  • •Patients already included in the study.
  • •Patient who couldn't be treated or followed up according to study criteria for psychological, social, family or geographical reasons. Patient deprived of liberty or under guardianship.

研究组 & 干预措施

Contrast-enhanced intraoperative ultrasound

Other

Contrast-enhanced intraoperative ultrasound

干预措施: Contrast-enhanced intraoperative ultrasound (Device)

结局指标

主要结局

Clinical Utility of Intraoperative Contrast Ultrasound in the Surgery of Colorectal Cancer Liver Metastases.

时间窗: At time of surgery

The clinical utility will be evaluated in terms of justified modification of the surgical procedure following contrast-enhanced intra-operative ultrasound (CE-IOUS), compared to the surgical procedure following conventional intra-operative ultrasound. For each patient, we will consider CE-IOUS to be clinically useful: * if the surgical procedure envisaged at the end of the CE-IOUS is different from the surgical procedure envisaged at the end of the conventional ultrasound * and if the surgical procedure envisaged at the end of the CE-IOUS is justified We reported the percentage of patients for whom there was a modified and justified surgical gesture following CE-IOUS.

次要结局

  • Description of Technical Arrangements for the CE-IOUS(At time of contrast-enhanced IOUS)
  • Performance Evaluation of Intraoperative Ultrasound Contrast: Detection Rate Per Lesion(up to 3 months after surgery)
  • Performance Evaluation of Intraoperative Ultrasound Contrast Per Lesion: Characterisation Rate(up to 3 months after surgery)
  • Clinical Utility of CE-IOUS in Subgroup of Patients Who Received Preoperative Chemotherapy(at time of surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验